DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice.
Aromatic amines such as 2-naphthylamine and 4-aminobiphenyl are established human bladder carcinogens. Experimental evidence for carcinogenicity of monocylic aromatic amines is limited mostly to other organs, but a recent epidemiologic study of bladder cancer found that 2,6-dimethyl- (2,6-DMA), 3,5-dimethyl- (3,5-DMA), and 3-ethylaniline (3-EA) may play a significant role in the etiology of this disease in man. The present work was undertaken to test whether a genotoxic mechanism can account for the presumptive activity of 2,6-DMA, 3,5-DMA, and 3-EA by quantifying the binding of these compounds to DNA in vivo. Each of these three [(14)C]alkylanilines was administered at approximately 100 microg/kg to C57BL/6 mice, which were subsequently sacrificed 2, 4, 8, 16, and 24 h post-dosing. Bladder, colon, kidney, liver, lung, and pancreas were harvested from each animal, and DNA was isolated from each tissue. Adduct levels were determined by quantifying bound isotope using accelerator mass spectrometry. Adducts were detectable in the bladder and liver DNA samples from every animal at every time point at levels that ranged from 3 per 10(9) to 1.5 per 10(7) nucleotides. Adduct levels were highest in animals given 3,5-DMA and lowest in those given 3-EA. Levels in both bladder and liver declined by severalfold over the course of the experiment. Adducts were detected less frequently in the other four tissues. Taken together, the results strongly suggest that these three alkylanilines are metabolized in vivo to electrophilic intermediates that covalently bind to DNA and that adducts are formed in the DNA of bladder, which is a putative target organ for these alkylanilines.
Skipper
Paul L
PL
Biological Engineering Division, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. skipper@ mit.edu
Trudel
Laura J
LJ
Kensler
Thomas W
TW
Groopman
John D
JD
Egner
Patricia A
PA
Liberman
Rosa G
RG
Wogan
Gerald N
GN
Tannenbaum
Steven R
SR
D000814:Aniline Compounds / Q000493:pharmacokinetics / Q000633:toxicity* / Q000652:urine; D000818:Animals; D004247:DNA / Q000378:metabolism*; D018736:DNA Adducts / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008297:Male; D013058:Mass Spectrometry; D051379:Mice; D008810:Mice, Inbred C57BL; D013329:Structure-Activity Relationship; D001743:Urinary Bladder / Q000378:metabolism
D000814:Aniline Compounds; D018736:DNA Adducts; C514328:3,5-dimethylaniline; C007766:2,6-xylidine; D004247:DNA; C514327:3-ethylaniline